Immunome, Inc. (IMNM)
20.84
+0.22
(+1.04%)
USD |
NASDAQ |
Mar 19, 16:00
20.84
0.00 (0.00%)
After-Hours: 19:56
Immunome Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 47.99% |
| Scholar Rock Holding Corp. | -- |
| Stoke Therapeutics, Inc. | -4.13K% |
| Nurix Therapeutics, Inc. | -576.1% |
| Prelude Therapeutics, Inc. | -291.8% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.14% |
| Return on Assets | -57.04% |
| Return on Invested Capital | -63.31% |
| Return on Net Operating Assets | -1.40K% |